On May 1, 2016, a motion for authority to obtain debtor-in-possession financing was filed in the bankruptcy case of BIND Therapeutics, Inc. and its affiliates.
The filing was assigned docket number 9 and is described on the court’s official docket as follows:
Motion to Approve Use of Cash Collateral // Motion of Debtors for Interim and Final Orders Pursuant to 11 U.S.C. §§ 105, 361, 362, 363, and 364 (I) Authorizing Use of Cash Collateral, (II) Granting Adequate Protection, (III) Scheduling a Final Hearing and (IV) Granting Related Relief Filed by BIND Therapeutics, Inc.. (Knight, John) (Entered: 05/01/2016)
BIND Therapeutics, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on May 1, 2016. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 16-11084. The bankruptcy case is currently assigned to United States Bankruptcy Judge Judge Not Yet Assigned. The law firm of Latham & Watkins LLP is acting as lead bankruptcy counsel to BIND Therapeutics, Inc. in the bankruptcy case.